Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma

Published:2012-10 Issue:10 Volume:12 Page:1283-1288
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Santini Daniele,Addeo Raffaele,Vincenzi Bruno,Calvieri Alice,Montella Liliana,Silletta Marianna,Caraglia Michele,Vespasiani Umberto,Picardi Antonio,Del Prete Salvatore,Tonini Giuseppe

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/era.12.102

Reference26 articles.

1. Global Cancer Statistics, 2002

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

3. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

4. Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma;Cells;2021-07-27

2. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon;Expert Review of Anticancer Therapy;2019-03-11

3. Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis;European Journal of Cancer;2018-12

4. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles;Acta Biomaterialia;2018-05

5. The role and mechanism of autophagy in sorafenib targeted cancer therapy;Critical Reviews in Oncology/Hematology;2016-04